Skip to content
Home/Companies/Healthcare/Spore.Bio
Spore.Bio

Spore.Bio

Healthcare·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Spore.Bio?

Spore.Bio is a French Healthcare company, currently owned by Singular Capital Partners since 2025.

Hand-verified · updated 2026-05-17

Open JSON · CC-BY
Singular Capital Partners
Investor
Singular Capital Partners
Singular Ventures II · 2023 · VC

Key facts

HQFrance
SectorHealthcare
StatusActive
Websitewww.spore.bio

More from Singular Ventures II

Other portfolio companies in the same fund.

Apoha
Active
Deep TechUK· 2026
Lucis
Lucis
Active
HealthTechFrance· 2026
Lupa
Lupa
Active
HealthTechUK· 2025
Manual
Manual
Active
HealthTechUK· 2025
Orus
Active
InsurTechFrance· 2025
Peec AI
Active
Data & AnalyticsGermany· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Spore.Bio?

Spore.Bio is currently owned by Singular Capital Partners, through Singular Ventures II, since 2025.

When did Singular Capital Partners acquire Spore.Bio?

Singular Capital Partners acquired Spore.Bio in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue